Increasing the effectiveness of treatment with continuous positive airways pressure (CPAP) using a weight-management program in overweight adults with sleep apnoea : the Sleeping Well Trial

Monash University0 个研究点目标入组 60 人开始时间: 2016年2月16日最近更新: 2020年2月3日

适应症

试验速览

暂无简介。

•Adults aged 19-68 years who have been newly diagnosed with moderate-severe untreated OSA with AHI greater than 20 events/hr (AASM alternate criteria) (demonstrated by prior overnight polysomnography [PSG]). Participants must be overweight with a body mass index (BMI) for Caucasians between 25 and 43 kg/m2 and for those of Asian and Indian descent 23 and 43 and self report a sedentary lifestyle ((self-reported exercise less than 2 days/week and a duration of less than 45 minutes per session. Eligible participants are required to be eligible to use Fixed-Pressure Continuous Positive Airway Pressure (CPAP).

•1. Pregnant women
•2. Diagnosed with concomitant obesity hypoventilation syndrome, Diabetes mellitus type 1, severe psychiatric disorder, and drowsiness
•3. Required to use VPAP or BPAP (variable/bilevel positive airway pressure)
•4. Unable to exercise (e.g. due to orthopedic or musculoskeletal problems)
•5. Previous surgical or current medical treatment for OSA
•6. Previous bariatric surgery
•7. Current use of weight loss programs and/or weight loss drugs
•8. Recent angina pectoris or atrial fibrillation
•9. Insufficient knowledge of English language to be able to consent
•10. Unable to provide informed consent

发起方